August 22, 2014 2:32 PM ET

Company Overview of National Disease Research Interchange

Company Overview


United States

Key Executives for National Disease Research Interchange

Chief Executive Officer and President
Vice President of Corporate Relations
Compensation as of Fiscal Year 2014.

National Disease Research Interchange Key Developments

National Disease Research Interchange Elects Board of Directors

National Disease Research Interchange has elected three new members to its board of directors including Mary J.C. Hendrix, PhD, president and scientific director for the Ann and Robert H. Lurie Children's Hospital of Chicago Research Center at Northwestern University's Feinberg School of Medicine in Chicago, Jonathan D. Moreno, PhD, professor of medical ethics and health policy at the University of Pennsylvania and a 2008-09 member of President Barack Obama's transition team, and Howard M. Nathan, president and CEO of the Philadelphia-based nonprofit Gift of Life Donor Program. Jonathan D. Moreno, PhD, is the David and Lyn Silfen University Professor at the University of Pennsylvania and is one of fifteen Penn Integrates Knowledge professors. At Penn he is also professor of medical ethics and health policy, professor of history and sociology of science, and professor of philosophy. Moreno is an elected member of the Institute of Medicine of the National Academy of Sciences and is the U.S. member of the UNESCO International Bioethics Committee. Moreno has served as an adviser to many governmental and non-governmental organizations, including three presidential commissions, the Department of Defense, the Department of Homeland Security, the Department of Health and Human Services, the Centers for Disease Control, the Federal Bureau of Investigation, the Howard Hughes Medical Institute, and the Bill and Melinda Gates Foundation.

National Disease Research Interchange Gets $5.9 Million by National Institutes of Health for Genotype-Tissue Project Scale Up

National Disease Research Interchange has been awarded $5,955,435 by the National Institutes of Health for the next phase of human tissue collection for the Genotype-Tissue Expression (GTEx) project--an NIH initiative begun in 2010 to investigate how genetic variation may relate to gene expression and its correlation with disease. NDRI and its partner organizations will use the funding over the next 15 months to procure 250 organ and tissue donors for researchers. The scale up is a 30-month project scheduled in 2, 15-month phases, with a goal of sourcing 700 additional donors. The $5.9 million awarded to NDRI is for the first, 15-month phase, during which NDRI will work with 5 organ procurement organizations to collect 150 organ donors and 100 tissue donors.

National Disease Research Interchange Hires Gene C. Kopen as Vice President, Corporate Relations

National Disease Research Interchange hired Gene C. Kopen as vice president, corporate relations. Kopen had been senior vice president, technology development, for Garnet Biotherapeutics.

Similar Private Companies By Industry

Company Name Region
Xstrata Nickel U.S. Inc. United States
M3 Entertainment Corporation United States
RecargaX, Inc. United States
American Medical Pharmaceutical Outlet United States
Molecular Technology Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact National Disease Research Interchange, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at